Bluepha to boost PHA bioplastics production with $30m fresh funding

China

5 min read

Mar 01, 2021

By Wang Xiao'e

The Beijing-based startup aims to produce 10,000 tons of PHA bioplastic a year and build a SynBio community through its STEM education spinoff, Bluepha Lab

Chinese biotech startup Bluepha has announced a $30m Series B funding round led by Lightspeed China Partners and GL Ventures. New investors Septwolves Venture Capital and Trinity Innovation Fund as well as existing investors Frees Fund, Qianhai FOF, Qihang Industrial Investment Fund and Frontier Enterprise Investment Fund joined the latest round.
The funding, the largest to be raised in a single round by a Chinese startup in the field of synthetic biology (SynBio), will mostly be used to build a factory that is expected to produce 10,000 tons of fully biodegradable polyhydroxyalkanoate (PHA...

The rest of the content is only available if you are logged in.

DATABASE

INSIGHTS

RESEARCH & ANALYSIS

FOLLOW US